Authors
Loading...
Preclinical evaluation demonstrates pH-triggered doxorubicin release from shear-thinning biomaterials in melanoma models, indicating improved localized drug delivery.
Lee et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: